CMT vs. ADMA
CMT (Core Molding Technologies, Inc.) and ADMA (ADMA Biologics, Inc.) are both stocks. CMT operates in Specialty Chemicals (Basic Materials), while ADMA operates in Biotechnology (Healthcare). Over the past 10 years, CMT returned 5.78%/yr vs 2.15%/yr for ADMA. At a 0.08 correlation, their price movements are largely independent.
Performance
CMT vs. ADMA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CMT achieves a 16.41% return, which is significantly higher than ADMA's -53.02% return. Over the past 10 years, CMT has outperformed ADMA with an annualized return of 5.78%, while ADMA has yielded a comparatively lower 2.15% annualized return.
CMT
- 1D
- -1.93%
- 1M
- -0.81%
- YTD
- 16.41%
- 6M
- 15.15%
- 1Y
- 41.97%
- 3Y*
- 4.95%
- 5Y*
- 8.59%
- 10Y*
- 5.78%
ADMA
- 1D
- 3.13%
- 1M
- 4.00%
- YTD
- -53.02%
- 6M
- -56.89%
- 1Y
- -51.69%
- 3Y*
- 30.34%
- 5Y*
- 38.86%
- 10Y*
- 2.15%
CMT vs. ADMA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CMT Core Molding Technologies, Inc. | 16.41% | 21.22% | -10.74% | 42.65% | 52.64% | -39.56% | 333.23% | -54.29% | -67.03% | 27.42% |
ADMA ADMA Biologics, Inc. | -53.02% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -25.55% | -37.30% |
Correlation
The correlation between CMT and ADMA is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Oct 17, 2013 | 0.08 |
Fundamentals
CMT:
$1.48
ADMA:
$0.68
CMT:
15.77
ADMA:
12.66
CMT:
0.56
ADMA:
4.11
CMT:
$270.93M
ADMA:
$509.86M
CMT:
$44.31M
ADMA:
$312.42M
CMT:
$18.05M
ADMA:
$218.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CMT vs. ADMA — Risk / Return Rank
CMT
ADMA
CMT vs. ADMA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Core Molding Technologies, Inc. (CMT) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CMT | ADMA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.97 | ||
| Sortino ratioReturn per unit of downside risk | +2.93 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 0.82 | +0.37 |
| Calmar ratioReturn relative to maximum drawdown | 2.12 | -0.83 | +2.95 |
| Martin ratioReturn relative to average drawdown | 4.00 | -1.66 | +5.66 |
Loading charts...
Drawdowns
CMT vs. ADMA - Drawdown Comparison
The maximum CMT drawdown since its inception was -96.21%, which is greater than ADMA's maximum drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for CMT and ADMA.
Loading charts...
Drawdown Indicators
| CMT | ADMA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.21% | -91.28% | -4.93% |
Max Drawdown (1Y)Largest decline over 1 year | -19.89% | -62.71% | +42.82% |
Max Drawdown (3Y)Largest decline over 3 years | -55.95% | -68.99% | +13.04% |
Max Drawdown (5Y)Largest decline over 5 years | -55.95% | -68.99% | +13.04% |
Max Drawdown (10Y)Largest decline over 10 years | -95.45% | -86.11% | -9.34% |
Current DrawdownCurrent decline from peak | -21.28% | -65.03% | +43.75% |
Average DrawdownAverage peak-to-trough decline | -53.30% | -53.07% | -0.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.51% | 31.23% | -20.72% |
Volatility
CMT vs. ADMA - Volatility Comparison
Core Molding Technologies, Inc. (CMT) has a higher volatility of 10.83% compared to ADMA Biologics, Inc. (ADMA) at 10.25%. This indicates that CMT's price experiences larger fluctuations and is considered to be riskier than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CMT | ADMA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.83% | 10.25% | +0.58% |
Volatility (6M)Calculated over the trailing 6-month period | 33.46% | 45.72% | -12.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.66% | 54.23% | -12.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.93% | 59.49% | -14.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.34% | 69.07% | -7.73% |
Dividends
CMT vs. ADMA - Dividend Comparison
Neither CMT nor ADMA has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CMT Core Molding Technologies, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.41% | 0.46% |
Financials
CMT vs. ADMA - Financials Comparison
This section allows you to compare key financial metrics between Core Molding Technologies, Inc. and ADMA Biologics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CMT vs. ADMA - Profitability Comparison
CMT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Core Molding Technologies, Inc. reported a gross profit of 11.98M and revenue of 58.58M. Therefore, the gross margin over that period was 20.5%.
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.
CMT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Core Molding Technologies, Inc. reported an operating income of 764.00K and revenue of 58.58M, resulting in an operating margin of 1.3%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.
CMT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Core Molding Technologies, Inc. reported a net income of 605.00K and revenue of 58.58M, resulting in a net margin of 1.0%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.
Frequently Asked Questions
CMT and ADMA have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CMT has higher volatility (10.83%) compared to ADMA (10.25%). In terms of maximum drawdown, CMT dropped -96.21% vs ADMA's -91.28%.
CMT currently has the higher Sharpe Ratio (1.01 vs -0.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CMT and ADMA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer